The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.
Open accessAbstract
The transcriptional activity of c-Jun is augmented through phosphorylation at two sites by a c-Jun amino-terminal kinase (JNK). All cells express two distinct JNK activities, 46 and 55 kD in size. It is not clear which of them is the more important c-Jun kinase and how they specifically recognize c-Jun. The 46-kD form of JNK was identified as a new member of the MAP kinase group of signal-transducing enzymes, JNK1. Here, we report the molecular cloning of the 55-kD form of JNK, JNK2, which exhibits 83% identity and similar regulation to JNK1. Despite this close similarity, the two JNKs differ greatly in their ability to interact with c-Jun. JNK2 binds c-Jun approximately 25 times more efficiently than JNK1, and as a result has a lower Km toward c-Jun than JNK1. The structural basis for this difference was investigated and traced to a small beta-strand-like region near the catalytic pocket of the enzyme. Modeling suggests that this region is solvent exposed and therefore is likely to serve as a docking site that increases the effective concentration of c-Jun near JNK2. These results explain how two closely related MAP kinases can differ in their ability to recognize specific substrates and thereby elicit different biological responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Almost 20 years ago, it was discovered that MAPKs contain a docking site in the C-terminal lobe that binds a conserved 13-16 amino acid sequence known as the D-or KIM-motif (kinase interaction motif).”
From Molecular basis of MAP kinase regulation (2013) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. R. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,040
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationThe stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,112
Self-citationHibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Self-citationBoulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Radzlejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos, N., Cobb, M. H., & Yancopoulos, G. D. (1991) · Cell · doi:10.1016/0092-8674(91)90098-j · Cited by 1,876
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,470
Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway
Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,433
Self-citationBoyle, W. J., van der Geer, P., & Hunter, T. R. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,421
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1
Angel, P., Hattori, K., Smeal, T., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90143-2 · Cited by 1,239
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 653
Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J., Jochum, W., Wagner, E. F., & Karin, M. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80065-7 · Cited by 302
Self-citationDifferential targeting of MAP kinases to the ETS‐domain transcription factor Elk‐1
Yang, S., Whitmarsh, A. J., Davis, R. J., & Sharrocks, A. D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1740 · Cited by 299
Self-citationLiou, A. K. F., Clark, R. S. B., Henshall, D. C., Yin, X., & Chen, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00005-4 · Cited by 295
HNE interacts directly with JNK isoforms in human hepatic stellate cells.
Parola, M., Robino, G., Marra, F., Pinzani, M., Bellomo, G., Leonarduzzi, G., Chiarugi, P., Camandola, S., Poli, G., Waeg, G., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1413 · Cited by 297
DeSilva, D. R., Jones, E. A., Favata, M. F., JAFFEE, B. D., Magolda, R. L., Trzăskos, J. M., & Scherle, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4175 · Cited by 295
Mitogen-Activated Protein Kinase Activation in UV-Induced Signal Transduction
Bode, A. M., & Dong, Z. (2003) · Science Signaling · doi:10.1126/stke.2003.167.re2 · Cited by 306
Molecular mechanisms of arsenic carcinogenesis
Huang, C., Ke, Q., Costa, M., & Shi, X. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007261.04684.78 · Cited by 286
Vogt, P. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204443 · Cited by 293
Smith, J. A., Poteet-Smith, C. E., Malarkey, K., & Sturgill, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2893 · Cited by 283
Docking Motif Interactions in MAP Kinases Revealed by Hydrogen Exchange Mass Spectrometry
Lee, T., Hoofnagle, A. N., Kabuyama, Y., Stroud, J., Min, X., Goldsmith, E. J., Chen, L., Resing, K. A., & Ahn, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00161-3 · Cited by 282
The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs)
Barr, R. K., & Bogoyevitch, M. A. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00093-0 · Cited by 285
Benn, J., Su, F., Doria, M., & Schneider, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.4978-4985.1996 · Cited by 281
Ito, M., Yoshioka, K., Akechi, M., Yamashita, S., Takamatsu, N., Sugiyama, K., Hibi, M., Nakabeppu, Y., Shiba, T., & Yamamoto, K.-I. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7539 · Cited by 279
Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3
Kelkar, N., Gupta, S., Dickens, M., & Davis, R. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1030-1043.2000 · Cited by 281
Self-citationThe structure of mitogen-activated protein kinase p38 at 2.1-Å resolution
Wang, Z., Harkins, P. C., Ulevitch, R. J., Han, J., Cobb, M. H., & Goldsmith, E. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2327 · Cited by 275
Timokhina, I., Kissel, H., Stella, G., & Besmer, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6250 · Cited by 265
Molecular mechanisms of curcumin action: Gene expression
Shishodia, S. (2012) · BioFactors · doi:10.1002/biof.1041 · Cited by 268
MAPK signaling pathways in the regulation of hematopoiesis
Geest, C. R., & Coffer, P. J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209097 · Cited by 267
Regulation of gene transcription by mitogen-activated protein kinase signaling pathways
Whitmarsh, A. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.011 · Cited by 274
Kontoyiannis, D. L., Kotlyarov, A., Carballo, E., Alexopoulou, L., Blackshear, P. J., Gaestel, M., Davis, R. J., Flavell, R. A., & Kollias, G. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3760 · Cited by 255
Self-citationSu, Y. C., Han, J., Xu, S., Cobb, M. H., & Skolnik, E. Y. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1279 · Cited by 256
Yang, S., Yates, P. R., Whitmarsh, A. J., Davis, R. J., & Sharrocks, A. D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.710 · Cited by 255
Self-citationChuang, S., Wang, I., & Yang, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.7.1423 · Cited by 252
Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors
Yang, S.-H., Galanis, A., & Sharrocks, A. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4028 · Cited by 244
Gerwins, P., Jonathan, L., & Johnson, G. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8288 · Cited by 242
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects
Bode, A. M., & Dong, Z. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00215-3 · Cited by 239
Specificity Determinants of Substrate Recognition by the Protein Kinase DYRK1A
Himpel, S., Tegge, W. J., Frank, R., Leder, S., Joost, H., & Becker, W. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2431 · Cited by 235
Sutherland, C., Heath, A. W., Pelech, S., Young, P. R., & Gold, M. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3381 · Cited by 234
Yao, M., Nguyen, T. V., & Pike, C. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4736-04.2005 · Cited by 233
Mendelson, K. G., Contois, L. W., Tevosian, S. G., Davis, R. J., & Paulson, K. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12908 · Cited by 232
Self-citationLiang, G., Wolfgang, C. D., Chen, B. P. C., Chen, T.-H., & Hai, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1695 · Cited by 231
Camp, H. S., Tafuri, S. R., & Leff, T. (1999) · Endocrinology · doi:10.1210/endo.140.1.6457 · Cited by 235
UV Irradiation and Heat Shock Mediate JNK Activation via Alternate Pathways
Adler, V., Schaffer, A., Kim, J., Dolan, L., & Ronai, Z. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26071 · Cited by 223
Jover, R., Bort, R., Gómez-Lechón, M. J., & Castell, J. V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0195fje · Cited by 222
Sabapathy, K., Kallunki, T., David, J., Graef, I. A., Karin, M., & Wagner, E. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.317 · Cited by 220
Self-citationIsolation of MEK5 and Differential Expression of Alternatively Spliced Forms
English, J. M., Vanderbilt, C. A., Xu, S., Marcus, S., & Cobb, M. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28897 · Cited by 213
Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity
Barr, R. K., Kendrick, T. S., & Bogoyevitch, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107565200 · Cited by 211
Okazaki, K., & Sagata, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00187.x · Cited by 211
Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo
Schiff, R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1926 · Cited by 211
Geng, Y., Valbracht, J., & Lotz, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119056 · Cited by 211
Activation of Rac GTPase by p75 Is Necessary for c- jun N-Terminal Kinase-Mediated Apoptosis
Harrington, A., Kim, J. Y., & Yoon, S. O. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00156.2002 · Cited by 208
Metalloprotease type III effectors that specifically cleave JNK and NF‐κB
Baruch, K., Gur-Arie, L., Nadler, C., Koby, S., Yerushalmi, G., Ben‐Neriah, Y., Yogev, O., Shaulian, E., Guttman, C., Zarivach, R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.297 · Cited by 208
Bogoyevitch, M. A., Ketterman, A. J., & Sugden, P. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29710 · Cited by 205
Riesgo‐Escovar, J. R., & Hafen, E. (1997) · Genes & Development · doi:10.1101/gad.11.13.1717 · Cited by 203
Liu, J., Minemoto, Y., & Lin, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10844-10856.2004 · Cited by 201
Crystal structure of JNK3: a kinase implicated in neuronal apoptosis
Xie, X., Gu, Y., Fox, T., Coll, J. T., Fleming, M. A., Markland, W., Caron, P. R., Wilson, K. P., & Su, M. S.-S. (1998) · Structure · doi:10.1016/s0969-2126(98)00100-2 · Cited by 198
Selective Activation of p38 MAPK Cascade and Mitotic Arrest Caused by Low Level Oxidative Stress
Kurata, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000308200 · Cited by 199
Pawlotsky, Y., Dantec, P. L., Moirand, R., Guggenbuhl, P., Jouanolle, A., Catheline, M., Meadeb, J.-M., Brissot, P., Deugnier, Y., & Chal�s, G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4 · Cited by 64
Dunn, C. A., Wiltshire, C. J., MacLaren, A., & Gillespie, D. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00275-3 · Cited by 187
Taylor, S. S., Radzio-Andzelm, E., & Hunter, T. R. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.13.7557015 · Cited by 188
Coffey, E. T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen, T., & Courtney, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04335.2002 · Cited by 184
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805677105 · Cited by 186
Self-citationBeltman, J., McCormick, F. P., & Cook, S. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27018 · Cited by 186
Mehan, S., Meena, H., Sharma, D., & Sankhla, R. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9454-6 · Cited by 185
Björkblom, B., Östman, N., Hongisto, V., Komarovski, V., Filén, J., Nyman, T. A., Kallunki, T., Courtney, M. J., & Coffey, E. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1517-05.2005 · Cited by 183
Self-citationZhang, J., Salojin, K. V., Gao, J., Cameron, M. J., Bergerot, I., & Delovitch, T. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3819 · Cited by 180
Bardwell, A. J., Flatauer, L. J., Matsukuma, K. E., Thorner, J. W., & Bardwell, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010271200 · Cited by 177
Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D., & Murata, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31648 · Cited by 175
Regulation of Metallothionein Transcription by the Metal-responsive Transcription Factor MTF-1
Saydam, N., Adams, T. K., Steiner, F. A., Schaffner, W., & Freedman, J. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110631200 · Cited by 174
The regulation of ATF3 gene expression by mitogen-activated protein kinases
Lü, D., Chen, J., & Hai, T. (2006) · Biochemical Journal · doi:10.1042/bj20061081 · Cited by 173
She, Q., Chen, N., Bode, A. M., Flavell, R. A., & Dong, Z. (2002) · PubMed · Cited by 173
Naumann, M., Weßler, S., Bartsch, C., Wieland, B., Covacci, A., Haas, R., & Meyer, T. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31655 · Cited by 172
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Alonso, I. G. D. L. F., Liang, H.-C., Turner, S. D., Lagger, S., Merkel, O., & Kenner, L. (2018) · Cancers · doi:10.3390/cancers10040093 · Cited by 167
Jiang, A., Craxton, A., Kurosaki, T., & Clark, E. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1297 · Cited by 170
Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage
Waetzig, V., & Herdegen, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.07.006 · Cited by 170
Stress‐activated signalling pathways in yeast
Toone, W. M., & Jones, N. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00211.x · Cited by 165
The 2 Faces of JNK Signaling in Cancer
Tournier, C. (2013) · Genes & Cancer · doi:10.1177/1947601913486349 · Cited by 163
Neuronal death and survival in two models of hypoxic-ischemic brain damage
Walton, M. R., Connor, B. J., Lawlor, P. A., Young, D., Sirimanne, E. S., Gluckman, P. D., Cole, G. M., & Dragunow, M. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00053-8 · Cited by 164
Bardwell, L., Cook, J. G., Chang, E. C., Cairns, B. R., & Thorner, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3637 · Cited by 161
JNK2 Is a Positive Regulator of the cJun Transcription Factor
Jaeschke, A., Karasarides, M., Ventura, J., Ehrhardt, A. G., Zhang, C., Flavell, R. A., Shokat, K. M., & Davis, R. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.028 · Cited by 163
Self-citationGaits‐Iacovoni, F., Degols, G., Shiozaki, K., & Russell, P. R. (1998) · Genes & Development · doi:10.1101/gad.12.10.1464 · Cited by 160
Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor
Antonyak, M. A., Moscatello, D. K., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2817 · Cited by 158
Jun N-Terminal Kinase in Rheumatoid Arthritis
Han, Z., Boyle, D. L., Aupperle, K. R., Bennett, B. L., Manning, A. M., & Firestein, G. S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35079-7 · Cited by 157
Kida, Y., Kobayashi, M., Suzuki, T., Takeshita, A., Okamatsu, Y., Hanazawa, S., Yasui, T., & Hasegawa, K. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.009 · Cited by 156
Tanaka, T., Kurokawa, M., Ueki, K., Tanaka, K., Imai, Y., Mitani, K., Okazaki, K., Sagata, N., Yazaki, Y., Shibata, Y., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3967 · Cited by 152
Nishina, H., Vaz, C., Billia, F., Nghiem, M. P., Sasaki, T., de la Pompa, J. L., Furlonger, K., Paige, C. J., Hui, C., Fischer, K., et al. (1999) · Development · doi:10.1242/dev.126.3.505 · Cited by 153
English, J. M., Pearson, G. W., Baer, R. J., & Cobb, M. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3854 · Cited by 151
Role of the JNK Pathway in Human Diseases
Sabapathy, K. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00013-4 · Cited by 149
Chen, R., Qin, Z., Ren, M., Kanai, H., Chalecka-Franaszek, E., Leeds, P. R., & Chuang, D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01548.x · Cited by 149
Tournier, C., Thomas, G., Pierre, J., Jacquemin, C., Pierre, M., & Saunier, B. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00587.x · Cited by 149
Xuhong, S. W., Diener, K., Jannuzzi, D., Trollinger, D. B., Tse-Hua, T., Lichenstein, H. S., Zukowski, M. M., & Yao, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31607 · Cited by 148
PATHOGENESIS OF RHEUMATOID ARTHRITIS: THE ROLE OF SYNOVIOCYTES
Yamanishi, Y., & Firestein, G. S. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70206-4 · Cited by 147
Wang, M., Ghosh, S., & Lengyel, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.359 · Cited by 148
Lindwall, C., Dahlin, L. B., Lundborg, G., & Kanje, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.001 · Cited by 147
Assefa, Z., Garmyn, M., Bouillon, R., Merlevede, W. J., Vandenheede, J. R., & Agostinis, P. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292595 · Cited by 146
Butterfield, L., Storey, B., Maas, L., & Heasley, L. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10110 · Cited by 146
Bost, F., McKay, R. A., Bost, M., Potapova, O., Dean, N. M., & Mercola, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1938 · Cited by 146
Sensitization to the Lysosomal Cell Death Pathway upon Immortalization and Transformation
Fehrenbacher, N., Gyrd‐Hansen, M., Poulsen, B., Felbor, U., Kallunki, T., Boes, M. L., Weber, E., Leist, M., & Jäättelä, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1427 · Cited by 144
Self-citationSubstrate and Docking Interactions in Serine/Threonine Protein Kinases
Goldsmith, E. J., Akella, R., Min, X., Zhou, T., & Humphreys, J. M. (2007) · Chemical Reviews · doi:10.1021/cr068221w · Cited by 143
Guan, Q., Pei, D., Zhang, Q., Hao, Z.-B., Xu, T., & Zhang, G. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.050 · Cited by 139
Bassuk, A. G., Anandappa, R. T., & Leiden, J. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3563-3573.1997 · Cited by 136
Potapova, O., Gorospe, M., Dougherty, R. H., Dean, N. M., Gaarde, W. A., & Holbrook, N. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1713-1722.2000 · Cited by 136
Dai, R., Frejtag, W., He, B., Zhang, Y., & Mivechi, N. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000958200 · Cited by 134
Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway
Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210526 · Cited by 133
Ghose, R., Zimmerman, T. L., Thevananther, S., & Karpen, S. J. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-4 · Cited by 135
Waetzig, V., Zhao, Y., & Herdegen, T. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.002 · Cited by 130
Signal transduction pathways: targets for chemoprevention of skin cancer
Bode, A. M., & Dong, Z. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00029-2 · Cited by 130
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Scapin, G., Patel, S. B., Lisnock, J., Becker, J. W., & LoGrasso, P. V. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00159-5 · Cited by 131
Toll-like Receptors from the Perspective of Cancer Treatment
Javaid, N., & Choi, S. (2020) · Cancers · doi:10.3390/cancers12020297 · Cited by 138
Targeting JNK3 for the treatment of neurodegenerative disorders
Resnick, L., & Fennell, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03251-9 · Cited by 128
Metadata
- Authors
- Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Dérijard, B., Moore, G., Davis, R., & Karin, M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1994-12-15
- Volume
- 8
- Issue
- 24
- Pages
- 2996-3007
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W1972145919
- Cited by
- 642
- References
- 34
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 15 · 2013: 15 · 2012: 21
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- JNK2, c-Jun, c-Jun N-terminal kinase, mitogen-activated protein kinase, substrate specificity, protein-protein interaction, c-Jun phosphorylation, docking site, catalytic pocket, JNK1, transcriptional activation, gene cloning
- MeSH terms
- Amino Acid Sequence, Binding Sites, Cell Line, Cloning, Molecular, Humans, Kinetics, Models, Molecular, Molecular Sequence Data, Molecular Weight, Protein Kinases, Transfection, Tumor Cells, Cultured, Gene Expression, Proto-Oncogene Proteins c-jun, Conserved Sequence, Sequence Homology, Amino Acid, Protein Structure, Secondary, Calcium-Calmodulin-Dependent Protein Kinases, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review